Frontlight ResearchEarly access
TerminatedNo phase
IRIS-BioFreedom Cohort in the IRIS-DES Registry
Key facts
- Who runs it
- Seung-Jung Park
- Where
- South Korea8 sites in 1 countryChoose a country to see its sites
- Trial code
- Status
- Terminated
- People taking part
- 218 people enrolled
- Started
- 20 May 2019
- Ended
- 29 Sept 2025
- Type of study
- Observational
- Treatments tested
- BIOFREEDOM™ FAMILY stent
- Record updated
- 30 September 2025
- Why it stopped
- Funding issue
Who can take part
- Age
- 19 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 6 criteriaShow less
Who can take part
- Age 19 and more
- Patient with BIOFREEDOM™ FAMILY stent
- Written consent
Who cannot take part
- Intervention with BIOFREEDOM™ FAMILY stent and other drug eluting stent at the same time
- Cardiac shock
- Life-expectancy less than 1 year
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The objective of this study is to evaluate effectiveness and safety of BIOFREEDOM™ FAMILY stent in the "real world" daily practice as compared with other drug-eluting stents.
The group in the trial
- Consecutive percutaneous coronary intervention
Treatment: BIOFREEDOM™ FAMILY stent
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Evaluation of Effectiveness and Safety of BIOFREEDOM™ FAMILY Stent in Routine Clinical Practice; A Multicenter, Prospective Observational Study
- Record updated
- 30 September 2025